EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis

Marta Feíto-Rodríguez iD, Ana Ramírez-Boscà, Santiago Vidal-Asensi iD, Diego Fernández-Nieto iD, Gonzalo Ros-Cervera iD, Vicent Alonso-Usero, David Prieto-Merino iD, Eva Núñez-Delegido iD, Beatriz Ruzafa-Costas iD, Pedro Sánchez-Pellicer iD, Salvador Genovés iD, Vicente Navarro-López iD

Clinical and Experimental Dermatology · 27.04.2023 · 48 (5) · 495-503

DOI: 10.1093/ced/llad007 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 13.01.2023. Verfasst von Marta Feíto-Rodríguez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital La Paz, Madrid, Spain. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Probiotics, Dermatologic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Biopolis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The intestinal microbiota is altered in patients with atopic dermatitis (AD) when compared with those of the healthy population. Some interventions with specific probiotic preparations already demonstrate a change in composition of this microbiota accompanied by improvement in the disease.

Objectives

This research work was designed to evaluate clinical efficacy of the probiotic preparation, and to measure the effect of the intervention on the total dose of corticosteroids administered to subjects.

Methods

This double-blind, randomized, placebo-controlled clinical trial including 70 participants with AD aged 4–17 years was designed to evaluate the clinical effect, compared with placebo, of a probiotic mixture of Bifidobacterium lactis, Bifidobacterium longum and Lactobacillus casei at a total daily consumption of 1 × 109 colony-forming units per capsule, over 12 weeks. After randomization and exclusion, 35 patients were allocated to probiotic and 35 to placebo. Clinical variables analysed were SCORAD (SCORing of Atopic Dermatitis) and Investigator Global Assessment (IGA) indices; effect on the amount of topical corticosteroids used; and assessment of safety.

Results

Mean SCORAD index at 12 weeks showed a statistically significant difference of −5.43 (95% confidence interval −10.65 to −0.21) between probiotic (SCORAD 13.52) and placebo groups (SCORAD 18.96); P = 0.04. Comparison between groups showed a statistically significant difference in the number of patients with IGA score improvement over the 12-week intervention: 29 of 32 (90.5%) in the probiotic group vs. 17 of 30 (56.7%) in the placebo group (P < 0.002). A comparison between groups of the proportions of days using corticosteroids and the total dose (g) of corticosteroids between baseline and end of study showed no significant difference, but between weeks 6 and 12 there was a statistically significant reduction in the probiotic group when compared with the placebo group in both variables. Numbers of adverse events were similar in both groups of treatment.

Conclusions

The probiotic mix used in this clinical trial demonstrated efficacy on the change in activity index of AD compared with placebo. Furthermore, the total number of days and total amount of topical corticosteroids required by participants in the probiotic group showed a significant reduction compared with placebo between 6 and 12 weeks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicProbioticsDermatologic AgentsHumansChildAdolescentAdrenal Cortex HormonesTreatment OutcomeGlucocorticoidsDouble-Blind MethodSeverity of Illness IndexImmunoglobulin A

Substanzen

Adrenal Cortex HormonesGlucocorticoidsDermatologic AgentsImmunoglobulin A

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital La Paz, Madrid, Spain.
  • Department of Dermatology, Centro Dermatológico-Estético, Alicante, Spain.
  • Department of Dermatology, Gómez-Ulla Military Hospital, Madrid, Spain.
  • Department of Dermatology, University Hospital Ramón y Cajal, Madrid, Spain.
  • Department of Pediatrics, University Hospital Vinalopó, Elche, Spain.
  • Department of Dermatology, Hospital Vithas Valencia 9 de Octubre, Valencia, Spain.

ORCID-Profile: Marta Feíto-Rodríguez, Santiago Vidal-Asensi, Diego Fernández-Nieto, Gonzalo Ros-Cervera, David Prieto-Merino, Eva Núñez-Delegido, Beatriz Ruzafa-Costas, Pedro Sánchez-Pellicer, Salvador Genovés, Vicente Navarro-López

Förderung

  • Biopolis

Zitieren

APA

Feíto-Rodríguez, M., Ramírez-Boscà, A., Vidal-Asensi, S., Fernández-Nieto, D., Ros-Cervera, G., Alonso-Usero, V., Prieto-Merino, D., Núñez-Delegido, E., Ruzafa-Costas, B., Sánchez-Pellicer, P., Genovés, S., & Navarro-López, V. (2023). Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis. Clinical and Experimental Dermatology, 48(5), 495-503. https://doi.org/10.1093/ced/llad007

Vancouver

Feíto-Rodríguez M, Ramírez-Boscà A, Vidal-Asensi S, Fernández-Nieto D, Ros-Cervera G, Alonso-Usero V, et al. Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis. Clinical and Experimental Dermatology. 2023;48(5):495-503. doi:10.1093/ced/llad007

BibTeX
@article{FetoRodrguez2023,
  author = {Feíto-Rodríguez, Marta and Ramírez-Boscà, Ana and Vidal-Asensi, Santiago and Fernández-Nieto, Diego and Ros-Cervera, Gonzalo and Alonso-Usero, Vicent and Prieto-Merino, David and Núñez-Delegido, Eva and Ruzafa-Costas, Beatriz and Sánchez-Pellicer, Pedro and Genovés, Salvador and Navarro-López, Vicente},
  title = {Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis},
  journal = {Clinical and Experimental Dermatology},
  year = {2023},
  volume = {48},
  number = {5},
  pages = {495--503},
  doi = {10.1093/ced/llad007}
}
Kostenlos starten →